Sunitinib inhibits inflammatory corneal lymphangiogenesis. [electronic resource]
Producer: 20130703Description: 3082-93 p. digitalISSN:- 1552-5783
- Angiogenesis Inhibitors -- therapeutic use
- Animals
- Cell Proliferation -- drug effects
- Corneal Neovascularization -- drug therapy
- Disease Models, Animal
- Enzyme Inhibitors -- therapeutic use
- Fluorescent Antibody Technique, Indirect
- Glycoproteins -- metabolism
- Indoles -- therapeutic use
- Lymphangiogenesis -- drug effects
- Lymphatic Vessels -- drug effects
- Macrophages, Peritoneal
- Male
- Membrane Transport Proteins
- Mice
- Mice, Inbred C57BL
- Placenta Growth Factor
- Platelet Endothelial Cell Adhesion Molecule-1 -- metabolism
- Pregnancy Proteins -- genetics
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrroles -- therapeutic use
- RNA, Messenger -- metabolism
- Rats
- Rats, Wistar
- Reverse Transcriptase Polymerase Chain Reaction
- Sunitinib
- Vascular Endothelial Growth Factor A -- genetics
- Vascular Endothelial Growth Factor Receptor-1 -- genetics
- Vascular Endothelial Growth Factor Receptor-2 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.